Edition:
India

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

20.35USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$20.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,606
52-wk High
$27.44
52-wk Low
$7.35

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $12.90
Shares Outstanding(Mil.): 0.74
Dividend: --
Yield (%): --

Financials

BRIEF-Acer Therapeutics Q4 Loss Per Share $0.63

* ACER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 Mar 2018

Competitors

Earnings vs. Estimates